for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Lupin Limited

LUPN.NS

Latest Trade

735.75INR

Change

17.00(+2.37%)

Volume

1,502,173

Today's Range

721.05

 - 

739.85

52 Week Range

646.30

 - 

906.00

As of on the National Stock Exchange of India ∙ Minimum 15 minute delay

Latest Developments

Lupin To Sell Entire Stake In Kyowa Pharmaceutical Industry

Nov 11 (Reuters) - Lupin Ltd <LUPN.NS>::APPROVED DIVESTMENT OF ITS ENTIRE EQUITY INTEREST (REPRESENTING 99.82% OF ISSUED AND PAID UP CAPITAL) IN KYOWA PHARMACEUTICAL INDUSTRY.DEAL FOR 57.26 BILLION YEN.SELLING STAKE IN KYOWA TO JAPANESE PE FIRM UNISON.POST TRANSACTION, CO'S NET DEBT WILL STAND AT 11.29 BILLION RUPEES VERSUS 43.62 BILLION RUPEES AS ON SEPT 30, 2019.POST TRANSACTION, NET DEBT TO EQUITY RATIO SHALL IMPROVE TO 0.08 VERSUS 0.32 AS ON SEPT 30, 2019.

India's Lupin Posts Sept Quarter Consol Net Loss

Nov 6 (Reuters) - Lupin Ltd <LUPN.NS>::SEPT QUARTER CONSOL NET LOSS 1.27 BILLION RUPEES VERSUS PROFIT OF 2.66 BILLION RUPEES YEAR AGO.CONSENSUS FORECAST FOR SEPT QUARTER CONSOL PROFIT WAS 3 BILLION RUPEES.SEPT QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 43.6 BILLION RUPEES VERSUS 39.51 BILLION RUPEES YEAR AGO.SEPT QUARTER EXCEPTIONAL ITEM 5.46 BILLION RUPEES.

Lupin Gets FDA Approval For Divalproex Sodium ER Tablets

Oct 22 (Reuters) - Lupin Ltd <LUPN.NS>::SAYS RECEIVES U.S. FDA APPROVAL FOR DIVALPROEX SODIUM ER TABLETS USP.

Lupin Gets Japan's PMDA Certificate To Mandideep Unit

Oct 9 (Reuters) - Lupin Ltd <LUPN.NS>::JAPAN''S PMDA ISSUES GMP CERTIFICATE TO LUPIN''S UNIT II MANDIDEEP FACILITY.GMP CERTIFICATE WAS ISSUED FOLLOWING AN INSPECTION WHICH CLOSED WITH NO CRITICAL OR MAJOR OBSERVATIONS..

U.S. FDA Makes 3 Observations at Lupin's Tarapur Facility

Sept 23 (Reuters) - Lupin Ltd <LUPN.NS>::U.S. FDA COMPLETES INSPECTION OF LUPIN'S TARAPUR FACILITY.FDA INSPECTION AT THE TARAPUR FACILITY CLOSED WITH THREE OBSERVATIONS.

Lupin Gets ANDA Approval From U.S. FDA For Levothyroxine Sodium Tablets USP

Sept 20 (Reuters) - Lupin Ltd <LUPN.NS>::GETS ANDA APPROVAL FROM U.S. FDA FOR LEVOTHYROXINE SODIUM TABLETS USP.

Lupin Says U.S. FDA Issues Warning Letter For Co's Mandideep Facility

Sept 19 (Reuters) - Lupin Ltd <LUPN.NS>::LUPIN LTD - U.S. FDA ISSUES WARNING LETTER FOR COMPANY'S MANDIDEEP FACILITY.LUPIN LTD - THERE ARE NO DMF AND ANDA APPLICATIONS PENDING REVIEW OR APPROVAL FROM MANDIDEEP FACILITY.LUPIN LTD - DOES NOT BELIEVE THAT WARNING LETTER WILL HAVE AN IMPACT ON DISRUPTION OF SUPPLIES OR EXISTING REVENUES FROM OPERATIONS OF FACILITY.

India's Lupin Geets U.S. FDA Approval For Fosaprepitant For Injection

Sept 6 (Reuters) - Lupin Ltd <LUPN.NS>::GETS U.S. FDA APPROVAL FOR FOSAPREPITANT FOR INJECTION.

Lupin And Boehringer Ingelheim Partner To Develop Oncology Drug To Treat KRAS-Driven Cancers

Sept 4 (Reuters) - Lupin Ltd <LUPN.NS>::LUPIN AND BOEHRINGER INGELHEIM ANNOUNCE PARTNERSHIP TO DEVELOP AND COMMERCIALIZE NOVEL ONCOLOGY DRUG TO TREAT KRAS-DRIVEN CANCERS..ANNOUNCE PARTNERSHIP TO DEVELOP AND COMMERCIALIZE NOVEL ONCOLOGY DRUG TO TREAT KRAS-DRIVEN CANCERS.SAYS TO RECEIVE A $20 MILLION UPFRONT PAYMENT WITH POTENTIAL TOTAL MILESTONES OF MORE THAN $700 MILLION.SAYS ALSO ENTITLED TO RECEIVE DOUBLE-DIGIT ROYALTIES ON SALES OF PRODUCT.PARTNERSHIP AIMS TO DEVELOP CO'S MEK INHIBITOR COMPOUND IN COMBINATION WITH ONE OF BOEHRINGER LNGELHEIM'S INNOVATIVE KRAS INHIBITORS.

Lupin South Africa Unit In Commercial Deal With Creso For Hemp Oil-Based Cannaqix

Aug 26 (Reuters) - Lupin Ltd <LUPN.NS>::SAYS ITS SUBSIDIARY IN SOUTH AFRICA ANNOUNCES COMMERCIAL AGREEMENT WITH CRESO PHARMA FOR HEMP OIL BASED CANNAQIX.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up